Effect of Depression Treatment on Somatic Depressive Symptoms and Cardiometabolic Biomarkers among People without Diabetes

Description

<p>Examining the effect of a modernized collaborative care intervention for depression consisting of both behavioral and pharmacologic treatments on 12-month change in individual somatic depressive symptoms (hyperphagia, poor appetite, hypersomnia, and disturbed sleep) and 12-month change in</p>
<p>cardiometabolic biomarkers (HOMA-IR, BMI, hsCRP, leptin, and ghrelin). Further examining whether 12-month change in individual somatic depressive symptoms mediates the eIMPACT intervention’s effect on 12-month change in cardiometabolic biomarkers.</p>

Links & Downloads

1. 10.25394/pgs.19878235.v1

Tags

Clinical psychology

Health psychology

diabetes biomarkers

Clinical Trial Randomization

BMI change

C-reactive protein

leptin levels

ghrelin levels

Additional Fields

Identifer	oai:union.ndltd.org:purdue.edu/oai:figshare.com:article/19878235
Date	09 September 2022
Creators	Aubrey Lynn Shell (6622241)
Source Sets	Purdue University
Detected Language	English
Type	Text, Thesis
Rights	CC BY 4.0
Relation	https://figshare.com/articles/thesis/Effect_of_Depression_Treatment_on_Somatic_Depressive_Symptoms_and_Cardiometabolic_Biomarkers_among_People_without_Diabetes/19878235